Boston Scientific Corp.

BSXNYSE • USD
44.34 USD
↗ 0.14 (0.32%)AT CLOSE (03:59 PM EST)
44.08
↘ 0.26 (0.59%)
POST MARKET (AS OF 08:14 PM EST)
Post Market
AS OF 08:14 PM EST
44.08
↘ 0.26 (0.59%)
🔴Market: CLOSED

BSX is currently priced at $44.34. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score and a bearish Death Cross on the long-term moving averages. Valuation metrics place BSX at a fair price relative to peers.

Technical & fundamental data as of Nov 13, 2026.

Open?$44.69
High?$44.69
Low?$44.08
Prev. Close?$44.20
Volume?9.7M
Avg. Volume?18.4M
VWAP?$44.31
Rel. Volume?0.53x
Bid / Ask
Bid?$43.66 × 300
Ask?$44.50 × 200
Spread?$0.84
Midpoint?$44.08
Valuation & Ratios
Market Cap?64.3B
Shares Out?1.4B
Float?1.4B
Float %?99.6%
P/E Ratio?18.35
P/B Ratio?2.51
EPS?$2.42
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Employees
59.0K
Market Cap
64.1B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
1992-05-18
Address
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH, MA 01752-1234
Phone: 508-683-4000
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
72
Momentum?
8
Short Sent.?
89
Piotroski F-Score?3/9Weak
Altman Z-Score?3.03Safe
Confidence?58%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?2.43%Low
Short Interest?35.1M
Days to Cover?1.7
Free Float1.4B
Avg Daily Volume21.3M
Settlement Date2026-10-30
Financial Health
Current Ratio?1.36Adequate
Quick Ratio?0.81Weak
Cash Ratio?0.10Low
Debt/Equity?0.47Low
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score
78/100
P/E?
Peers
73
S&P
70
18.4FAIR▾
P/B?
Peers
78
S&P
64
2.51CHEAP▾
P/S?
Peers
55
S&P
50
3.05FAIR▾
P/FCF?
Peers
64
S&P
58
19.3CHEAP▾
EV/EBITDA?
Peers
64
S&P
64
12.7FAIR▾
EV/Sales?
Peers
45
S&P
52
3.59FAIR▾
Returns & Efficiency
ROE?
Peers
67
S&P
50
13.7%STRONG▾
ROA?
Peers
91
S&P
64
7.7%STRONG▾
Cash Flow & Enterprise
FCF?$3.3B
Enterprise Value?$75.6B
Fundamentals ratios updated end of day